Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study-Reference-Cited by-同舟云学术

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study

Published:2002-07-01 Issue:1 Volume:50 Page:37-45
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:
Short-container-title:Cancer Chemotherapy and Pharmacology

Author:

Martell Robert,Peterson Bercedis,Cohen Harvey,Petros William,Rai Kanti,Morrison Vicki,Elias Laurence,Shepherd Lois,Hines John,Larson Richard,Schiffer Charles,Hurwitz Herbert

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-002-0443-5.pdf

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical study of the human recombinant Erythropoietin (GBPD002) compared with Eprex^®;2024-06-06

2. Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?;Frontiers in Immunology;2023-11-22

3. Biochemical and Hematologic Profiles in B-Cell Acute Lymphoblastic Leukemia Children;Journal of Pediatric Hematology/Oncology;2023-07-14

4. Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning;Blood Advances;2022-07-01

5. Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia;Therapeutic Advances in Hematology;2022-01